Related Experiment Video
Updated: Jan 20, 2026
10:19
Video Tracking Protocol to Screen Deterrent Chemistries for Honey Bees
Published on: June 12, 2017
7.0K
We Built It, But They Are Not Coming: Exploring Deterrents to Consumer Medication Information Use
Helen Monkman1, Andre W Kushniruk1, Jeff Barnett1
1School of Health Information Science, University of Victoria, Victoria, British Columbia, Canada.
Studies in Health Technology and Informatics
|August 22, 2019
Summary
Consumer Medication Information (CMI) leaflets are often not used by patients. This study identified documentation, provision, and context as key factors influencing CMI use, suggesting further research is needed.
Area of Science:
- Health Communication
- Patient Education
- Medication Adherence
Background:
- Prescription medication use is widespread, necessitating consumer awareness of benefits and risks.
- Consumer Medication Information (CMI) leaflets are provided with first-time prescriptions in North America.
- Reported utilization rates for written medication information remain low.
Purpose of the Study:
- To investigate reported deterrents to the use of Consumer Medication Information (CMI).
- To identify factors influencing patient engagement with medication information leaflets.
Main Methods:
- Exploratory study examining patient perceptions, preferences, and information needs related to CMI.
- Analysis of reported barriers to CMI utilization within a broader investigation.
Main Results:
- Three primary areas influencing CMI use were identified: Documentation (design and content), Provision (delivery method and timing), and Context (individual characteristics and experiences).
- These factors collectively impact whether consumers engage with provided medication information.
Conclusions:
- Documentation, provision, and context are significant factors affecting CMI use.
- Further research is recommended to explore the nuances and relative impact of these factors on CMI utilization.
Keywords:
Consumer Medication InformationPatient Medication InformationPrescription Drug Information LeafletsWritten Medication InformationMore Related Videos
09:17Using a Virtual Store As a Research Tool to Investigate Consumer In-store Behavior
Published on: July 24, 2017
11.8K
05:32Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
Published on: August 11, 2023
2.5K
Related Concept Videos
01:23Inhaled Medications
760
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
760
01:30Heart Failure V: Medical Management
225
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
225
01:18Endocarditis III: Medical Management
217
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
217
01:14Myocarditis III: Medical Management
181
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
181
01:17Pericarditis III: Medical Management
319
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
319
01:26Nephrotic Syndrome II : Assessment and Medical Management
211
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
211